HARRISON THOMAS L

CIK 000124734010 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001247340

Recent Transactions

50 trades

Award
AGENUS INC$AGEN
Common Stock
2026-01-02$3.98/sh+7,691→ 29,770 total
Award
Advanced Flower Capital Inc.$AFCG
Common Stock
2025-11-20$2.74/sh+5,474→ 24,539 total
Award
AGENUS INC$AGEN
Common Stock
2025-10-01$5.01/sh+5,780→ 22,079 total
Award
AGENUS INC$AGEN
Common Stock
2025-07-01$3.46/sh+7,401→ 16,299 total
Award
AGENUS INC$AGEN
Stock Option
2025-06-17+17,500→ 30,000 total
Award
AGENUS INC$AGEN
Common Stock
2025-04-01$2.88/sh+8,898→ 8,898 total
Award
Advanced Flower Capital Inc.$AFCG
Common Stock
2025-02-25$8.37/sh+1,792→ 19,065 total
Award
AGENUS INC$AGEN
Stock Option
2024-08-07+7,500→ 7,500 total
Award
Acurx Pharmaceuticals, Inc.$ACXP
Stock Option
2024-06-17+12,000→ 12,000 total
Award
Advanced Flower Capital Inc.$AFCG
Common Stock
2024-01-24$11.70/sh+1,282→ 17,273 total
Award
Acurx Pharmaceuticals, Inc.$ACXP
Stock Option
2023-06-15+10,000→ 10,000 total
Award
Advanced Flower Capital Inc.$AFCG
Common Stock
2023-01-03$15.57/sh+963→ 15,991 total
Award
Advanced Flower Capital Inc.$AFCG
Stock Option (right to buy)
2022-01-11+5,000→ 5,000 total
Award
Acurx Pharmaceuticals, Inc.$ACXP
Stock Option
2021-07-01+50,000→ 50,000 total
Purchase
Advanced Flower Capital Inc.$AFCG
Common Stock
2021-03-23$19.00/sh+5,000→ 15,028 total
Award
Advanced Flower Capital Inc.$AFCG
Stock Option (right to buy)
2021-03-23+700→ 700 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-06-06+15,000→ 15,000 total
Sale
Fifth Street Asset Management Inc.
Class A Common Stock, $0.01 par value per share
2017-12-08$4.05/sh−6,000→ 0 total
Sale
Fifth Street Asset Management Inc.
Class A Common Stock, $0.01 par value per share
2017-11-30$4.07/sh−20,000→ 0 total
Exercise/Conversion
Fifth Street Asset Management Inc.
Option (right to buy)
2017-11-30−20,000→ 0 total
Exercise/Conversion
Fifth Street Asset Management Inc.
Class A Common Stock, $0.01 par value per share
2017-11-30$3.28/sh+20,000→ 20,000 total
Exercise/Conversion
Fifth Street Asset Management Inc.
Class A Common Stock, $0.01 par value per share
2017-11-30$3.28/sh+20,000→ 26,000 total
Sale
Fifth Street Asset Management Inc.
Class A Common Stock, $0.01 par value per share
2017-11-30$4.07/sh−20,000→ 6,000 total
Exercise/Conversion
Fifth Street Asset Management Inc.
Option (right to buy)
2017-11-30−20,000→ 0 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2017-10-02$5.47/sh+2,057→ 2,057 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2017-07-03$10.63/sh+1,058→ 1,058 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2017-06-07+15,000→ 15,000 total
Award
Fifth Street Asset Management Inc.
Option (right to buy)
2017-05-04+5,000→ 5,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2017-04-03$12.77/sh+880→ 880 total
Award
PLx Pharma Winddown Corp.
Options
2017-01-17+20,000→ 20,000 total
Award
Fifth Street Asset Management Inc.
Option (right to buy)
2016-06-16+5,000→ 5,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2016-05-25+15,000→ 15,000 total
Award
Fifth Street Asset Management Inc.
Option (right to buy)
2016-03-14+20,000→ 20,000 total
Award
PLx Pharma Winddown Corp.
Options
2016-01-19$10.16/sh+18,000→ 18,000 total
Purchase
Zynerba Pharmaceuticals, Inc.
Common Stock
2015-08-10$14.00/sh+12,500→ 12,500 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option
2015-08-04+35,000→ 35,000 total
Award
Fifth Street Asset Management Inc.
Option (right to buy)
2015-06-04+5,000→ 5,000 total
Award
PLx Pharma Winddown Corp.
Options
2015-01-05$11.35/sh+15,000→ 15,000 total
Purchase
Fifth Street Asset Management Inc.
Class A Common Stock, $0.01 par value per share
2014-11-04$17.00/sh+6,000→ 6,000 total
Award
Fifth Street Asset Management Inc.
Option (right to buy)
2014-10-29+10,000→ 10,000 total
Purchase
PLx Pharma Winddown Corp.
Common Stock, par value $.001 per share
2014-03-18$12.00/sh+2,000→ 148,832 total
Award
RVUE HOLDINGS, INC.
Common Stock
2013-12-03+500,000→ 1,500,000 total
Purchase
RVUE HOLDINGS, INC.
Common Stock
2013-12-03$0.07/sh+1,000,000→ 1,000,000 total
Disposition to Issuer
EPOCRATES INC
Non-Qualified Stock Option (right to buy)
2013-03-12−15,720→ 0 total
Disposition to Issuer
EPOCRATES INC
Non-Qualified Stock Option (right to buy)
2013-03-12−15,720→ 0 total
Disposition to Issuer
EPOCRATES INC
Non-Qualified Stock Option (right to buy)
2013-03-12−15,720→ 0 total
Disposition to Issuer
EPOCRATES INC
Non-Qualified Stock Option (right to buy)
2013-03-12−11,790→ 0 total
Disposition to Issuer
EPOCRATES INC
Non-Qualified Stock Option (right to buy)
2013-03-12−15,720→ 0 total
Disposition to Issuer
EPOCRATES INC
Non-Qualified Stock Option (right to buy)
2013-03-12−11,790→ 0 total
Disposition to Issuer
EPOCRATES INC
Non-Qualified Stock Option (right to buy)
2013-03-12−15,720→ 0 total

Companies

Recent Filings

Address

C/O MORGANS HOTEL GROUP CO. 475 TENTH AVENUE

NEW YORK, NY, 10018

View on SEC.gov